Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia

Ordóñez, KarenFeinstein, Max M.Reyes, SergioHernández Gómez, CristhianPallares, Christian JoséVillegas, María Virginia2019-09-142019-09-1420191413-8670https://hdl.handle.net/20.500.12495/1699application/pdfengAttribution-NonCommercial-NoDerivatives 4.0 InternationalClinical and economic impact of generic versus brand name meropenem use in an intensive care unit in ColombiaarticleCostos de los medicamentosCuidados críticosBacteriasGeneric drugsMeropenemMortalityhttps://doi.org/10.1016/j.bjid.2019.06.010instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coAcceso abiertoinfo:eu-repo/semantics/openAccesshttps://purl.org/coar/access_right/c_abf2352019